261 related articles for article (PubMed ID: 21978836)
1. Synthesis and structure-activity relationship studies of 4-arylthiosemicarbazides as topoisomerase IV inhibitors with Gram-positive antibacterial activity. Search for molecular basis of antibacterial activity of thiosemicarbazides.
Siwek A; Stączek P; Stefańska J
Eur J Med Chem; 2011 Nov; 46(11):5717-26. PubMed ID: 21978836
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship studies of microbiologically active thiosemicarbazides derived from hydroxybenzoic acid hydrazides.
Plech T; Paneth A; Kaproń B; Kosikowska U; Malm A; Strzelczyk A; Stączek P
Chem Biol Drug Des; 2015 Mar; 85(3):315-25. PubMed ID: 25043121
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and characterization of novel tetrahydropyran-based bacterial topoisomerase inhibitors with potent anti-gram-positive activity.
Surivet JP; Zumbrunn C; Rueedi G; Hubschwerlen C; Bur D; Bruyère T; Locher H; Ritz D; Keck W; Seiler P; Kohl C; Gauvin JC; Mirre A; Kaegi V; Dos Santos M; Gaertner M; Delers J; Enderlin-Paput M; Boehme M
J Med Chem; 2013 Sep; 56(18):7396-415. PubMed ID: 23968485
[TBL] [Abstract][Full Text] [Related]
4. Biological and docking studies of topoisomerase IV inhibition by thiosemicarbazides.
Siwek A; Stączek P; Wujec M; Stefańska J; Kosikowska U; Malm A; Jankowski S; Paneth P
J Mol Model; 2011 Sep; 17(9):2297-303. PubMed ID: 21080016
[TBL] [Abstract][Full Text] [Related]
5. Thiosemicarbazide Derivatives Decrease the ATPase Activity of
Kowalczyk A; Paneth A; Trojanowski D; Paneth P; Zakrzewska-Czerwińska J; Stączek P
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33918623
[TBL] [Abstract][Full Text] [Related]
6. Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
Hossion AM; Zamami Y; Kandahary RK; Tsuchiya T; Ogawa W; Iwado A; Sasaki K
J Med Chem; 2011 Jun; 54(11):3686-703. PubMed ID: 21534606
[TBL] [Abstract][Full Text] [Related]
7. Isothiazolopyridones: synthesis, structure, and biological activity of a new class of antibacterial agents.
Wiles JA; Hashimoto A; Thanassi JA; Cheng J; Incarvito CD; Deshpande M; Pucci MJ; Bradbury BJ
J Med Chem; 2006 Jan; 49(1):39-42. PubMed ID: 16392790
[TBL] [Abstract][Full Text] [Related]
8. Biological evaluation and molecular modelling study of thiosemicarbazide derivatives as bacterial type IIA topoisomerases inhibitors.
Paneth A; Stączek P; Plech T; Strzelczyk A; Dzitko K; Wujec M; Kuśmierz E; Kosikowska U; Grzegorczyk A; Paneth P
J Enzyme Inhib Med Chem; 2016; 31(1):14-22. PubMed ID: 25792505
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of ciprofloxacin-sulfonamide hybrids to manipulate ciprofloxacin pharmacological qualities: Potency and side effects.
Ibrahim NM; Fahim SH; Hassan M; Farag AE; Georgey HH
Eur J Med Chem; 2022 Jan; 228():114021. PubMed ID: 34871841
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antibacterial activity of a novel series of potent DNA gyrase inhibitors. Pyrazole derivatives.
Tanitame A; Oyamada Y; Ofuji K; Fujimoto M; Iwai N; Hiyama Y; Suzuki K; Ito H; Terauchi H; Kawasaki M; Nagai K; Wachi M; Yamagishi J
J Med Chem; 2004 Jul; 47(14):3693-6. PubMed ID: 15214796
[TBL] [Abstract][Full Text] [Related]
11. Novel 3-fluoro-6-methoxyquinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV.
Mitton-Fry MJ; Brickner SJ; Hamel JC; Barham R; Brennan L; Casavant JM; Ding X; Finegan S; Hardink J; Hoang T; Huband MD; Maloney M; Marfat A; McCurdy SP; McLeod D; Subramanyam C; Plotkin M; Reilly U; Schafer J; Stone GG; Uccello DP; Wisialowski T; Yoon K; Zaniewski R; Zook C
Bioorg Med Chem Lett; 2017 Aug; 27(15):3353-3358. PubMed ID: 28610977
[TBL] [Abstract][Full Text] [Related]
12. Design, green one-pot synthesis and molecular docking study of novel N,N-bis(cyanoacetyl)hydrazines and bis-coumarins as effective inhibitors of DNA gyrase and topoisomerase IV.
Metwally NH; Abdallah SO; Mohsen MMA
Bioorg Chem; 2020 Apr; 97():103672. PubMed ID: 32145481
[TBL] [Abstract][Full Text] [Related]
13. 3-aminoquinazolinediones as a new class of antibacterial agents demonstrating excellent antibacterial activity against wild-type and multidrug resistant organisms.
Ellsworth EL; Tran TP; Showalter HD; Sanchez JP; Watson BM; Stier MA; Domagala JM; Gracheck SJ; Joannides ET; Shapiro MA; Dunham SA; Hanna DL; Huband MD; Gage JW; Bronstein JC; Liu JY; Nguyen DQ; Singh R
J Med Chem; 2006 Nov; 49(22):6435-8. PubMed ID: 17064062
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antimicrobial activity of thiosemicarbazides, s-triazoles and their Mannich bases bearing 3-chlorophenyl moiety.
Plech T; Wujec M; Siwek A; Kosikowska U; Malm A
Eur J Med Chem; 2011 Jan; 46(1):241-8. PubMed ID: 21130541
[TBL] [Abstract][Full Text] [Related]
15. Synergistic Effects of Thiosemicarbazides with Clinical Drugs against
Chudzik-Rząd B; Malm A; Trotsko N; Wujec M; Plech T; Paneth A
Molecules; 2020 May; 25(10):. PubMed ID: 32422899
[TBL] [Abstract][Full Text] [Related]
16. Discovery of substituted oxadiazoles as a novel scaffold for DNA gyrase inhibitors.
Jakopin Ž; Ilaš J; Barančoková M; Brvar M; Tammela P; Sollner Dolenc M; Tomašič T; Kikelj D
Eur J Med Chem; 2017 Apr; 130():171-184. PubMed ID: 28246042
[TBL] [Abstract][Full Text] [Related]
17. Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationships.
Charifson PS; Grillot AL; Grossman TH; Parsons JD; Badia M; Bellon S; Deininger DD; Drumm JE; Gross CH; LeTiran A; Liao Y; Mani N; Nicolau DP; Perola E; Ronkin S; Shannon D; Swenson LL; Tang Q; Tessier PR; Tian SK; Trudeau M; Wang T; Wei Y; Zhang H; Stamos D
J Med Chem; 2008 Sep; 51(17):5243-63. PubMed ID: 18690678
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of peptides from bacterial ParE toxin as inhibitors of topoisomerases.
Barbosa LC; Garrido SS; Garcia A; Delfino DB; Santos Ldo N; Marchetto R
Eur J Med Chem; 2012 Aug; 54():591-6. PubMed ID: 22749642
[TBL] [Abstract][Full Text] [Related]
19. Novel quinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV.
Mitton-Fry MJ; Brickner SJ; Hamel JC; Brennan L; Casavant JM; Chen M; Chen T; Ding X; Driscoll J; Hardink J; Hoang T; Hua E; Huband MD; Maloney M; Marfat A; McCurdy SP; McLeod D; Plotkin M; Reilly U; Robinson S; Schafer J; Shepard RM; Smith JF; Stone GG; Subramanyam C; Yoon K; Yuan W; Zaniewski RP; Zook C
Bioorg Med Chem Lett; 2013 May; 23(10):2955-61. PubMed ID: 23566517
[TBL] [Abstract][Full Text] [Related]
20. Structure activity relationship of pyridoxazinone substituted RHS analogs of oxabicyclooctane-linked 1,5-naphthyridinyl novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-6).
Singh SB; Kaelin DE; Wu J; Miesel L; Tan CM; Meinke PT; Olsen DB; Lagrutta A; Wei C; Liao Y; Peng X; Wang X; Fukuda H; Kishii R; Takei M; Yajima M; Shibue T; Shibata T; Ohata K; Nishimura A; Fukuda Y
Bioorg Med Chem Lett; 2015 Sep; 25(17):3636-43. PubMed ID: 26141771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
